Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis

Brain

Volumn 125, Issue 7, 2002, Pages 1522-1533

  Menzies, Fiona M ^a   Cookson, Mark R ^c,e   Taylor, Robert W ^b   Turnbull, Douglass M ^b   Chrzanowska Lightowlers, Zofia M A ^b   Dong, Lichun ^d   Figlewicz, Denise A ^d   Shaw, Pamela J ^a,f  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Cu Zn superoxide dismutase; Mitochondria; Motor neurones; Oxidative stress

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL CULTURE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ELECTRON TRANSPORT; GENETIC TRANSFECTION; GLYCOLYSIS; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOTONEURON; NEUROPATHOLOGY; PRIORITY JOURNAL;

EID: 0036310142     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf167     Document Type: Article

References (56)

1. Genetics of amyotrophic lateral sclerosis: An overview
2. Mitochondrial dysfunction in neurodegenerative diseases
3. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
4. ALS, SOD and peroxynitrite
5. The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death
6. Cytoplasmic abnormalities in cultured cerebellar neurones from the trisomy 16 mouse
7. Effect of peroxynitrite on the mitochondrial respiratory chain: Differential susceptibility of neurones and astrocytes in primary culture
8. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death
9. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis
10. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase
11. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis
12. Aggregation and motor neurone toxicity of an ALS- linked SOD1 mutant dependent from wild-type SOD1
13. 2+ concentration in transfected neuroblastoma SH-SY5Y cells
14. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurones
15. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases
16. Oxidation versus aggregation - How do SOD1 mutations cause ALS?
17. Cytochrome c oxidase subunit I microdeletion in a patient with motor neurone disease
18. Oxidative stress and motor neurone disease
19. Peroxynitrite and hydrogen peroxide induced cell death in the NSC34 neuroblastoma x spinal cord cell line: Role of poly(ADP·ribose) polymerase
20. Mitochondria in organismal aging and degeneration
21. Mitochondrial DNA deletion mutation levels are 'elevated in ALS brains
22. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS
23. Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis
24. Rat liver Cu, Zn-superoxide dismutase. Subcellular location in lysosomes
25. Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis
26. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration and premature motoneurone death and accelerates motoneurone disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1
27. Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations
28. Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis
29. Chronic mitochondrial inhibition induces selective motoneurone death in vitro: A new model for amyotrophic lateral sclerosis
30. Massive mitochondrial degeneration in motor neurones triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
31. Increased hydroxyl radical production and apoptosis in PC12 neurone cells expressing the gain-of-function mutant G93A SOD1 gene
32. Mitochondrial involvement in amyotrophic lateral sclerosis
33. Superoxide dismutase is an abundant component in cell bodies, dendrites and axons of motor neurones and in a subset of other neurones
34. Electron transport chain defects in Alzheimer's disease brain
35. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells
36. Inhibition of mitochondrial electron transport by peroxynitrite
37. Free radical damage to mitochondria
38. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy
39. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
40. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1
41. Ultrastructural study of synapses in the anterior horn neurones of patients with amyotrophic lateral sclerosis
42. Apoptosis in amyotrophic lateral sclerosis: A review of the evidence
43. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia
44. 2+ signaling and mitochondrial deficiencies in hippocampal neurones of trisomy 16 mice: A model of Down's syndrome
45. Glutamate, excitotoxicity and amyotrophic lateral sclerosis
46. Molecular factors underlying selective vulnerability of motor neurones to neurodegeneration in amyotrophic lateral sclerosis
47. Immunocytochemical study of the distribution of the free radical scavenging enzymes Cu/Zn superoxide dismutase (SOD1); MN superoxide dismutase (MN SOD) and catalase in the normal human spinal cord and in motor neurone disease
48. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement
49. A fraction of yeast Cu/Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria: A physiological role for SOD1 in guarding against mitochondrial oxidative damage
50. Mitochondria in sporadic amyotrophic lateral sclerosis
51. Laboratory diagnosis of mitochondrial disease
52. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis
53. Mitochondrial superoxide dismutase
54. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis
55. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide
56. The oxidative inactivation of mitochondrial electron transport chain components and ATPase